The Overselling of Hormone Replacement Therapy
- 1 September 2002
- journal article
- review article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 22 (9) , 1205-1208
- https://doi.org/10.1592/phco.22.13.1205.33521
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Cardiovascular Disease Outcomes During 6.8 Years of Hormone TherapyJAMA, 2002
- Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable anginaJournal of the American College of Cardiology, 2002
- Effects of hormone replacement therapy on clinical fractures and height loss: the heart and estrogen/progestin replacement study (HERS)The American Journal of Medicine, 2001
- Effects of Estrogen Replacement on the Progression of Coronary-Artery AtherosclerosisNew England Journal of Medicine, 2000
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Long-term postmenopausal hormone use, obesity, and fat distribution in older womenPublished by American Medical Association (AMA) ,1996
- Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased?BMJ, 1994
- Postmenopausal Estrogen and Prevention BiasAnnals of Internal Medicine, 1991
- Characteristics of noncontraceptive hormone usersPreventive Medicine, 1988